Isoptin SR 240 mg Prolonged-Release Tablets Malta - English - Medicines Authority

isoptin sr 240 mg prolonged-release tablets

viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - prolonged-release tablet - verapamil hydrochloride 240 mg - calcium channel blockers

Brufen Retard 800mg prolonged release tablets Ireland - English - HPRA (Health Products Regulatory Authority)

brufen retard 800mg prolonged release tablets

viatris healthcare limited - ibuprofen - prolonged-release tablet - propionic acid derivatives; ibuprofen

JANUMET XR 100/1000 sitagliptin (as phosphate monohydrate)/metformin hydrochloride 100 mg/1000 mg extended release tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

janumet xr 100/1000 sitagliptin (as phosphate monohydrate)/metformin hydrochloride 100 mg/1000 mg extended release tablet bottle

merck sharp & dohme (australia) pty ltd - metformin hydrochloride, quantity: 1000 mg; sitagliptin phosphate monohydrate, quantity: 128.5 mg (equivalent: sitagliptin, qty 100 mg) - tablet, modified release - excipient ingredients: povidone; hypromellose; colloidal anhydrous silica; sodium stearylfumarate; propyl gallate; macrogol 3350; kaolin; carnauba wax; titanium dioxide; hyprolose; indigo carmine aluminium lake - janumet xr (sitagliptin phosphate monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.,[see sections 5.1 pharmacodynamic properties, clinical trials and 4.2 dose and method of administration].

JANUMET XR 50/1000 sitagliptin (as phosphate monohydrate)/metformin hydrochloride 50 mg/1000 mg extended release tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

janumet xr 50/1000 sitagliptin (as phosphate monohydrate)/metformin hydrochloride 50 mg/1000 mg extended release tablet bottle

merck sharp & dohme (australia) pty ltd - metformin hydrochloride, quantity: 1000 mg; sitagliptin phosphate monohydrate, quantity: 64.25 mg (equivalent: sitagliptin, qty 50 mg) - tablet, modified release - excipient ingredients: povidone; hypromellose; colloidal anhydrous silica; sodium stearylfumarate; propyl gallate; macrogol 3350; kaolin; carnauba wax; titanium dioxide; hyprolose; iron oxide yellow; indigo carmine aluminium lake - janumet xr (sitagliptin phosphate monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.,[see sections 5.1 pharmacodynamic properties, clinical trials and 4.2 dose and method of administration].

Metabet SR 1000mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

metabet sr 1000mg tablets

morningside healthcare ltd - metformin hydrochloride - modified-release tablet - 1gram

Glucophage XR 1000 mg Prolonged-Release Tablet Kenya - English - Pharmacy and Poisons Board

glucophage xr 1000 mg prolonged-release tablet

merck (pty) ltd 1 friesland drive,longmeadow bussiness - metformin hydrochloride - prolonged-release tablet - 1000 mg metformin hydrochloride per tablet - metformin

Voltaren Retard 75 mg prolonged release tablets Malta - English - Medicines Authority

voltaren retard 75 mg prolonged release tablets

nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - prolonged-release tablet - diclofenac sodium 75 mg - antiinflammatory and antirheumatic products